Caris Life Sciences (CAI) Non-Current Assets (2024 - 2026)

Caris Life Sciences has reported Non-Current Assets for 3 years, with the latest figure at $171.8 million in Q2 2026.

• On a quarterly basis, Non-Current Assets rose 41.12% year-over-year to $171.8 million in Q2 2026; TTM through Jun 2026 was $578.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $127.9 million, changed 0.11% from the prior year.
• Non-Current Assets was $171.8 million for Q2 2026 at Caris Life Sciences, up from $148.2 million in the prior quarter.
• The five-year high for Non-Current Assets was $171.8 million in Q2 2026, with the low at $121.7 million in Q2 2025.
• Average Non-Current Assets over 3 years is $138.0 million, with a median of $129.2 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Non-Current Assets slipped 0.11% in 2025, then soared 41.12% in 2026.
• Over 3 years, Non-Current Assets stood at $128.0 million in 2024, then decreased by 0.11% to $127.9 million in 2025, then jumped by 34.36% to $171.8 million in 2026.
• The last three Non-Current Assets figures came in at $171.8 million (Q2 2026), $148.2 million (Q1 2026), and $127.9 million (Q4 2025), per Business Quant data.